CeLLogix cellular bone matrix is a viable allogeneic bone allograft containing viable bone-derived cells
CeLLogix Product Features
Osteoconductive three-dimensional scaffold with cortical & cancellous components
DMSO-free cryoprotectant with no rinsing and decanting steps required
Bone-derived cells to support osteogenic healing processes
Four hour working window for implantation after thaw without loss of cell viability
Minimum of 150,000 viable cells per cc of allograft post-thaw³
Demineralized bone scaffold with osteoinductive potential, which provides exposure of signaling molecules and bone morphogenetic proteins¹
Proprietary, optimized bone microparticulate size range of 100-300 μm²
Convenient handling and preparation time in the OR
Average cell viability exceeds 80% post-thaw³
Product shelf-life is two years from date of processing when stored at -65°C or colder
Reference:
1. Study evaluated the bone ongrowth of PEEK-OPTIMA and PEEK-OPTIMA HA Enhanced in a bone defect model in sheep. Data on file at Invibio. This has not been correlated with human clinical experience
2. J. Henkel, M. A. Woodruff, D. R. Epari, R. Steck, V. Glatt, I. C. Dickinson, P. F. M. Choong, M. A. Schuetz, D. W. Hutmacher. Bone Regeneration Based on Tissue Engineering Conceptions — A 21st Century Perspective. Bone Research (2013) 1, 216–248.
CeLLogix Product Brochure
